23 results on '"Sharpe, Arlene H."'
Search Results
2. The B7/CD28 costimulatory family in autoimmunity.
- Author
-
Keir, Mary E. and Sharpe, Arlene H.
- Subjects
- *
AUTOIMMUNITY , *IMMUNE response , *ANTIGENS , *T cells , *CELL receptors - Abstract
Host defense is dependent on the appropriate induction of immune responses. A central concept in immunology is the ability of the immune system to differentiate foreign from self-antigens. The failure of the immune response to recognize foreign pathogens can result in infection and disease in the host. The inappropriate response of the immune system to self-antigens is equally problematic, leading to autoimmune disease. Central and peripheral tolerance mechanisms control self-reactive T-cell responses and protect peripheral tissues from autoimmune attack. This review examines the roles of B7/CD28 family members, which can augment or antagonize T-cell receptor signaling, in the regulation of central and peripheral T-cell tolerance. We also discuss how B7/CD28 pathways influence both T-cell-intrinsic and -extrinsic mechanisms of regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
3. A new therapeutic strategy for malaria: targeting T cell exhaustion.
- Author
-
Freeman, Gordon J and Sharpe, Arlene H
- Subjects
- *
T cells , *MALARIA treatment , *IMMUNE response , *PLASMODIUM falciparum , *IMMUNOPATHOLOGY , *LABORATORY mice - Published
- 2012
- Full Text
- View/download PDF
4. The B7:CD28 family and friends: Unraveling coinhibitory interactions.
- Author
-
Burke, Kelly P., Chaudhri, Apoorvi, Freeman, Gordon J., and Sharpe, Arlene H.
- Subjects
- *
IMMUNOREGULATION , *IMMUNE response , *GRAFT rejection , *FAMILY roles , *IMMUNE system - Abstract
Immune responses must be tightly regulated to ensure both optimal protective immunity and tolerance. Costimulatory pathways within the B7:CD28 family provide essential signals for optimal T cell activation and clonal expansion. They provide crucial inhibitory signals that maintain immune homeostasis, control resolution of inflammation, regulate host defense, and promote tolerance to prevent autoimmunity. Tumors and chronic pathogens can exploit these pathways to evade eradication by the immune system. Advances in understanding B7:CD28 pathways have ushered in a new era of immunotherapy with effective drugs to treat cancer, autoimmune diseases, infectious diseases, and transplant rejection. Here, we discuss current understanding of the mechanisms underlying the coinhibitory functions of CTLA-4, PD-1, PD-L1:B7-1 and PD-L2:RGMb interactions and less studied B7 family members, including HHLA2, VISTA, BTNL2, and BTN3A1, as well as their overlapping and unique roles in regulating immune responses, and the therapeutic potential of these insights. Tight regulation of immune responses is critical. In this review, Sharpe and colleagues review inhibitory members of the B7-CD28 family and their roles in regulating immune responses with an emphasis on CTLA-4, PD-1, and the increasingly complex network of cis and trans interactions with their ligands in lymphoid organs and the periphery with implications for infection, autoimmunity, and anti-tumor immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. SECOND SIGNALS: TRANSLATING UNDERSTANDING INTO THERAPY.
- Author
-
Sharpe, Arlene H.
- Subjects
- *
T cells , *IMMUNE response , *LYMPHOCYTES , *CHIMERIC antigen receptors , *ALLOIMMUNITY - Abstract
The article focuses on the regulation of immune responses by an exquisite system of on and off signals that allows tolerance as well as protective immunity. The important role of T cell costimulation in regulating immune responses is mentioned. Therapeutic manipulation of T cell costimulatory pathways which offers a means either to enhance immune responses that can cure diseases is cited.
- Published
- 2017
6. Dendritic cells giveth and taketh away.
- Author
-
Abbas, Abul K and Sharpe, Arlene H
- Subjects
- *
DENDRITIC cells , *T cells , *CELLULAR therapy , *IMMUNOLOGY , *ANTIGENS , *IMMUNE response - Abstract
The article focuses on the research on dendritic cells (DCs) showing that tolerance induced by resting DCs is dependent on engagement of the T cell inhibitory receptors PD-1 and CTLA-4. DCs are the principal cell type that display peptide antigens for the initiation of adaptive immune responses involving T cells and are also capable of shutting lymphocytes off, thus inducing tolerance in T cells. It remains unclear why resting DCs might preferentially engage inhibitory receptors of T cells. One hypothesis is that this phenomenon is related to the expression of costimulatory ligands and the affinities of activating versus inhibitory receptors for these ligands. A different but not mutually exclusive mechanism is that inhibition simply reflects a change in the activation threshold of T cells.
- Published
- 2005
- Full Text
- View/download PDF
7. T-Cell Costimulation — Biology, Therapeutic Potential, and Challenges.
- Author
-
Sharpe, Arlene H. and Abbas, Abul K.
- Subjects
- *
T cells , *IMMUNE response , *IMMUNOLOGY , *CELLS , *CELLULAR therapy - Abstract
The authors reflect on the biology, therapeutic potential and challenges of T-cell costimulation. They say that T-cells are key mediators of the immune response, and their activation is tightly regulated to prevent autoreactivity. They add that the significant role of costimulation in regulating T-cell activation versus tolerance has stimulated great interest in the manipulation of costimulatory signals to either boost immune responses or induce tolerance.
- Published
- 2006
- Full Text
- View/download PDF
8. The PD-1 pathway in tolerance and autoimmunity.
- Author
-
Francisco, Loise M., Sage, Peter T., and Sharpe, Arlene H.
- Subjects
- *
AUTOIMMUNITY , *MEMBRANE proteins , *T cells , *IMMUNE response , *HOMEOSTASIS - Abstract
Regulatory T cells (Tregs) and the PD-1: PD-ligand (PD-L) pathway are both critical to terminating immune responses. Elimination of either can result in the breakdown of tolerance and the development of autoimmunity. The PD-1: PD-L pathway can thwart self-reactive T cells and protect against autoimmunity in many ways. In this review, we highlight how PD-1 and its ligands defend against potentially pathogenic self-reactive effector T cells by simultaneously harnessing two mechanisms of peripheral tolerance: (i) the promotion of Treg development and function and (ii) the direct inhibition of potentially pathogenic self-reactive T cells that have escaped into the periphery. Treg cells induced by the PD-1 pathway may also assist in maintaining immune homeostasis, keeping the threshold for T-cell activation high enough to safeguard against autoimmunity. PD-L1 expression on non-hematopoietic cells as well as hematopoietic cells endows PD-L1 with the capacity to promote Treg development and enhance Treg function in lymphoid organs and tissues that are targets of autoimmune attack. At sites where transforming growth factor-β is present (e.g. sites of immune privilege or inflammation), PD-L1 may promote the de novo generation of Tregs. When considering the consequences of uncontrolled immunity, it would be therapeutically advantageous to manipulate Treg development and sustain Treg function. Thus, this review also discusses how the PD-1 pathway regulates a number of autoimmune diseases and the therapeutic potential of PD-1: PD-L modulation. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides.
- Author
-
Ruiz-Perez, Begonia, Chung, Doo R., Sharpe, Arlene H., Yagita, Hideo, Kalka-Moll, Wiltrud M., Sayegh, Mohamed H., Kasper, Dennis L., and Tzianabos, Arthur O.
- Subjects
- *
LYMPHOCYTES , *POLYSACCHARIDES , *BIOMOLECULES , *IMMUNOGLOBULINS , *IMMUNE response , *FIBROSIS - Abstract
Bacterial carbohydrates have long been considered T cell-independent antigens that primarily induce humoral immune responses. Recently, it has been demonstrated that bacterial capsules that possess a zwitterionic charge motif can activate CD4+ T cells after processing and presentation by antigen-presenting cells. Here we show that these zwitterionic polysaccharides can prevent I helper 1-mediated fibrosis by signaling for the release of IL-10 from CD4+ T cells in vivo. IL-10 production by these T cells and their ability to prevent fibrosis is controlled by the inducible costimulator (ICOS)- ICOS ligand pathway. These data demonstrate that the interaction of the zwitterionic polysaccharides with T cells results in modulation of surgical fibrosis in vivo and suggest a previously undescribed approach to "harnessing" I cell function to prevent inflammatory tissue disorders in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
10. THE B7 FAMILY REVISITED.
- Author
-
Greenwald, Rebecca J., Freeman, Gordon J., and Sharpe, Arlene H.
- Subjects
- *
T cells , *LYMPHOCYTES , *TISSUES , *B cells , *IMMUNE response , *PHYSIOLOGICAL control systems - Abstract
The discovery of new functions for the original B7 family members, together with the identification of additional B7 and CD28 family members, have revealed new ways in which the B7:CD28 family regulates T cell activation and tolerance. B7-1/B7-2:CD28 interactions not only promote initial T cell activation but also regulate self-tolerance by supporting CD4+CD25+ T regulatory cell homeostasis. CTLA-4 can exert its inhibitory effects in both B7-1/B7-2 dependent and independent fashions. B7-1 and B7-2 can signal bidirectionally by engaging CD28 and CTLA-4 on T cells and by delivering signals into B7-expressing cells. The five new B7 family members, ICOS ligand, PD-L1 (B7-H1), PD-L2 (B7-DC), B7-H3, and B7-H4 (B7x/B7-S1) are expressed on professional antigen-presenting cells as well as on cells within nonlymphoid organs, providing new means for regulating T cell activation and tolerance in peripheral tissues. The new CD28 families members, ICOS, PD-1, and BTLA, are inducibly expressed on T cells, and they have important roles in regulating previously activated T cells. PD-1 and BTLA also are expressed on B cells and may have broader immunoregulatory functions. The ICOS:ICOSL pathway appears to be particularly important for stimulating effector T cell responses and T cell-dependent B cell responses, but it also has an important role in regulating T cell tolerance. In addition, the PD-1:PD-L1/PD-L2 pathway plays a critical role in regulating T cell activation and tolerance. In this review, we revisit the roles of the B7:CD28 family members in regulating immune responses, and we discuss their therapeutic potential. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
11. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin.
- Author
-
Ryeom, Sandra, Greenwald, Rebecca J., Sharpe, Arlene H., and McKeon, Frank
- Subjects
- *
GENE expression , *IMMUNE response , *CARDIOVASCULAR system , *T cells , *CELL death - Abstract
Calcineurin links calcium signaling to transcriptional responses in the immune, nervous and cardiovascular systems. To determine the function of the calcipressins, a family of putative calcineurin inhibitors, we assessed the calcineurin-dependent process of T cell activation in mice engineered to lack the gene encoding calcipressin 1 (Csp1). Csp1 regulated calcineurin in vivo, and genes triggered in an immune response had unique transactivation thresholds for T cell receptor stimulation. In the absence of Csp1, the apparent transactivation thresholds for all these genes were shifted because of enhanced calcineurin activity. This unbridled calcineurin activity drove Fas ligand expression, which normally requires high T cell receptor stimulation and results in the premature death of T helper type 1 cells. Thus, calcipressins modulate the pattern of calcineurin-dependent transcription, and may influence calcineurin activity beyond calcium to integrate a broad array of signals into the cellular response. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
12. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
- Author
-
Chen, Ivy X., Newcomer, Kathleen, Pauken, Kristen E., Juneja, Vikram R., Naxerova, Kamila, Wu, Michelle W., Pinter, Matthias, Sen, Debattama R., Singer, Meromit, Sharpe, Arlene H., and Jain, Rakesh K.
- Subjects
- *
SUPPRESSOR cells , *METASTATIC breast cancer , *IMMUNE response , *T cells , *COUPLES therapy - Abstract
Immune checkpoint blockade (ICB) is efficacious in many diverse cancer types, but not all patients respond. It is important to understand the mechanisms driving resistance to these treatments and to identify predictive biomarkers of response to provide best treatment options for all patients. Here we introduce a resection and responseassessment approach for studying the tumormicroenvironment before or shortly after treatment initiation to identify predictive biomarkers differentiating responders from nonresponders. Our approach builds on a bilateral tumor implantation technique in a murine metastatic breast cancer model (E0771) coupled with anti-PD-1 therapy. Using our model, we show that tumors from mice responding to ICB therapy had significantly higher CD8+ T cells and fewer Gr1+CD11b+ myeloidderived suppressor cells (MDSCs) at early time points following therapy initiation. RNA sequencing on the intratumoral CD8+ T cells identified the presence of T cell exhaustion pathways in nonresponding tumors and T cell activation in responding tumors. Strikingly, we showed that our derived response and resistance signatures significantly segregate patients by survival and associate with patient response to ICB. Furthermore, we identified decreased expression of CXCR3 in nonresponding mice and showed that tumors grown in Cxcr3−/− mice had an elevated resistance rate to anti-PD-1 treatment. Our findings suggest that the resection and response tumor model can be used to identify response and resistance biomarkers to ICB therapy and guide the use of combination therapy to further boost the antitumor efficacy of ICB. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice.
- Author
-
Ron-Harel, Noga, Notarangelo, Giulia, Ghergurovich, Jonathan M., Paulo, Joao A., Sage, Peter T., Santos, Daniel, Satterstrom, F. Kyle, Gygi, Steven P., Rabinowitz, Joshua D., Sharpe, Arlene H., and Haigis, Marcia C.
- Subjects
- *
T cells , *CELL respiration , *CARBON metabolism , *BIOTRANSFORMATION (Metabolism) , *MICE physiology , *MAMMAL aging , *IMMUNE response , *MITOCHONDRIA formation - Abstract
T cell-mediated immune responses are compromised in aged individuals, leading to increased morbidity and reduced response to vaccination. While cellular metabolism tightly regulates T cell activation and function, metabolic reprogramming in aged T cells has not been thoroughly studied. Here, we report a systematic analysis of metabolism during young versus aged naïve T cell activation. We observed a decrease in the number and activation of naïve T cells isolated from aged mice. While young T cells demonstrated robust mitochondrial biogenesis and respiration upon activation, aged T cells generated smaller mitochondria with lower respiratory capacity. Using quantitative proteomics, we defined the aged T cell proteome and discovered a specific deficit in the induction of enzymes of one-carbon metabolism. The activation of aged naïve T cells was enhanced by addition of products of onecarbon metabolism (formate and glycine). These studies define mechanisms of skewed metabolic remodeling in aged T cells and provide evidence that modulation of metabolism has the potential to promote immune function in aged individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
14. Inhibitors of the PD-1 Pathway in Tumor Therapy.
- Author
-
LaFleur, Martin W., Yuki Muroyama, Drake, Charles G., and Sharpe, Arlene H.
- Subjects
- *
PROGRAMMED cell death 1 receptors , *CELLULAR signal transduction , *CELL communication , *TUMORS , *IMMUNE response , *ANTINEOPLASTIC agents , *GENE therapy - Abstract
The programmed death 1 (PD-1) pathway delivers inhibitory signals that function as a brake for immune responses. This pathway limits the initiation and duration of immune responses, thereby protecting tissues from immune-mediated damage and autoimmune diseases. However, the PD-1 pathway also inhibits immune responses to tumors. The critical role of PD-1 in preventing antitumor immunity is demonstrated by the transformative effects of PD-1 pathway blockade in a broad range of cancers with the hallmark of durability of response. Despite this success, most patients do not respond to PD-1 monotherapy, and some patients experience adverse events. In this review, we discuss the functions of the PD-1 pathway and its translation to cancer immunotherapy. We also consider current challenges and opportunities for PD-1 cancer immunotherapy, including mechanisms of response and resistance, identification of biomarkers of response to PD-1 therapy, characterization and treatment of PD-1 therapy-related adverse events, and development of safe and effective combination therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
- Author
-
Schildberg, Frank A., Klein, Sarah R., Freeman, Gordon J., and Sharpe, Arlene H.
- Subjects
- *
RECEPTOR-ligand complexes , *IMMUNE response , *IMMUNITY , *HOMEOSTASIS , *INFECTION - Abstract
Immune responses need to be controlled for optimal protective immunity and tolerance. Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate immune homeostasis and defense and protect tissue integrity. These coinhibitory signals limit the strength and duration of immune responses, thereby curbing immune-mediated tissue damage, regulating resolution of inflammation, and maintaining tolerance to prevent autoimmunity. Tumors and microbes that cause chronic infections can exploit these coinhibitory pathways to establish an immunosuppressive microenvironment, hindering their eradication. Advances in understanding T cell coinhibitory pathways have stimulated a new era of immunotherapy with effective drugs to treat cancer, autoimmune and infectious diseases, and transplant rejection. In this review we discuss the current knowledge of the mechanisms underlying the coinhibitory functions of pathways in the B7-CD28 family, the diverse functional consequences of these inhibitory signals on immune responses, and the overlapping and unique functions of these key immunoregulatory pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses.
- Author
-
Joller, Nicole, Lozano, Ester, Burkett, Patrick?R., Patel, Bonny, Xiao, Sheng, Zhu, Chen, Xia, Junrong, Tan, Tze?G., Sefik, Esen, Yajnik, Vijay, Sharpe, Arlene?H., Quintana, Francisco?J., Mathis, Diane, Benoist, Christophe, Hafler, David?A., and Kuchroo, Vijay?K.
- Subjects
- *
T helper cells , *CELLULAR control mechanisms , *INFLAMMATION , *ENZYME inhibitors , *IMMUNE response , *CELL proliferation - Abstract
Summary: Foxp3+ T regulatory (Treg) cells regulate immune responses and maintain self-tolerance. Recent work shows that Treg cells are comprised of many subpopulations with specialized regulatory functions. Here we identified Foxp3+ T cells expressing the coinhibitory molecule TIGIT as a distinct Treg cell subset that specifically suppresses proinflammatory T helper 1 (Th1) and Th17 cell, but not Th2 cell responses. Transcriptional profiling characterized TIGIT+ Treg cells as an activated Treg cell subset with high expression of Treg signature genes. Ligation of TIGIT on Treg cells induced expression of the effector molecule fibrinogen-like protein 2 (Fgl2), which promoted Treg-cell-mediated suppression of T effector cell proliferation. In addition, Fgl2 was necessary to prevent suppression of Th2 cytokine production in a model of allergic airway inflammation. TIGIT expression therefore identifies a Treg cell subset that demonstrates selectivity for suppression of Th1 and Th17 cell but not Th2 cell responses. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
17. Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses.
- Author
-
Mott, Kevin R., Allen, Sariah J., Zandian, Mandana, Akbari, Omid, Hamrah, Pedram, Maazi, Hadi, Wechsler, Steven L., Sharpe, Arlene H., Freeman, Gordon J., and Ghiasi, Homayon
- Subjects
- *
CD80 antigen , *RECOMBINANT viruses , *CELL physiology , *T cells , *DENDRITIC cells , *IMMUNE response , *HERPES simplex prevention , *VIRAL replication - Abstract
CD80 plays a critical role in stimulation of T cells and subsequent control of infection. To investigate the effect of CD80 on HSV-1 infection, we constructed a recombinant HSV-1 virus that expresses two copies of the CD80 gene in place of the latency associated transcript (LAT). This mutant virus (HSV-CD80) expressed high levels of CD80 and had similar virus replication kinetics as control viruses in rabbit skin cells. In contrast to parental virus, this CD80 expressing recombinant virus replicated efficiently in immature dendritic cells (DCs). Additionally, the susceptibility of immature DCs to HSV-CD80 infection was mediated by CD80 binding to PD-L1 on DCs. This interaction also contributed to a significant increase in T cell activation. Taken together, these results suggest that inclusion of CD80 as a vaccine adjuvant may promote increased vaccine efficacy by enhancing the immune response directly and also indirectly by targeting to DC. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. Circulatory Antigen Processing by Mucosal Dendritic Cells Controls CD8+ T Cell Activation
- Author
-
Chang, Sun-Young, Song, Joo-Hye, Guleng, Bayasi, Cotoner, Carmen Alonso, Arihiro, Seiji, Zhao, Yun, Chiang, Hao-Sen, O’Keeffe, Michael, Liao, Gongxian, Karp, Christopher L., Kweon, Mi-Na, Sharpe, Arlene H., Bhan, Atul, Terhorst, Cox, and Reinecker, Hans-Christian
- Subjects
- *
ANTIGEN processing , *MUCOUS membranes , *DENDRITIC cells , *CD8 antigen , *T cells , *SMALL intestine immunology , *LYMPHATICS , *IMMUNE response - Abstract
Summary: Circulatory antigens transit through the small intestine via the fenestrated capillaries in the lamina propria prior to entering into the draining lymphatics. But whether or how this process controls mucosal immune responses remains unknown. Here we demonstrate that dendritic cells (DCs) of the lamina propria can sample and process both circulatory and luminal antigens. Surprisingly, antigen cross-presentation by resident CX3CR1+ DCs induced differentiation of precursor cells into CD8+ T cells that expressed interleukin-10 (IL-10), IL-13, and IL-9 and could migrate into adjacent compartments. We conclude that lamina propria CX3CR1+ DCs facilitate the surveillance of circulatory antigens and act as a conduit for the processing of self- and intestinally absorbed antigens, leading to the induction of CD8+ T cells, that partake in the control of T cell activation during mucosal immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
19. Interleukin-4 Production by Follicular Helper T Cells Requires the Conserved Il4 Enhancer Hypersensitivity Site V
- Author
-
Vijayanand, Pandurangan, Seumois, Grégory, Simpson, Laura J., Abdul-Wajid, Sarah, Baumjohann, Dirk, Panduro, Marisella, Huang, Xiaozhu, Interlandi, Jeneen, Djuretic, Ivana M., Brown, Daniel R., Sharpe, Arlene H., Rao, Anjana, and Ansel, K. Mark
- Subjects
- *
INTERLEUKIN-4 , *T cells , *ALLERGIES , *LYMPHOID tissue , *IMMUNE response , *MOLECULAR biology , *IMMUNOGLOBULIN G - Abstract
Summary: Follicular helper T cells (Tfh cells) are the major producers of interleukin-4 (IL-4) in secondary lymphoid organs where humoral immune responses develop. Il4 regulation in Tfh cells appears distinct from the classical T helper 2 (Th2) cell pathway, but the underlying molecular mechanisms remain largely unknown. We found that hypersensitivity site V (HS V; also known as CNS2), a 3′ enhancer in the Il4 locus, is essential for IL-4 production by Tfh cells. Mice lacking HS V display marked defects in type 2 humoral immune responses, as evidenced by abrogated IgE and sharply reduced IgG1 production in vivo. In contrast, effector Th2 cells that are involved in tissue responses were far less dependent on HS V. HS V facilitated removal of repressive chromatin marks during Th2 and Tfh cell differentiation and increased accessibility of the Il4 promoter. Thus, Tfh and Th2 cells utilize distinct but overlapping molecular mechanisms to regulate Il4, a finding with important implications for understanding the molecular basis of allergic diseases. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
20. Overexpression of the CTLA-4 Isoform Lacking Exons 2 and 3 Causes Autoimmunity.
- Author
-
Liu, Sue M., Sutherland, Andrew P. R., Zheng Zhang, Rainbow, Daniel B., Quintana, Francisc J., Paterson, Alison M., Sharpe, Arlene H., Oukka, Mohamed, Wicker, Linda S., and Kuchroo, Vijay K.
- Subjects
- *
AUTOIMMUNITY , *T cells , *EXONS (Genetics) , *LABORATORY mice , *AUTOANTIBODIES , *CYTOKINES , *IMMUNE response - Abstract
CTLA-4 is a potent inhibitor of T cell activation, primarily upon binding to its costimulatory ligands (B7.1 and B7.2) expressed on APCs. However, variants of CTLA-4 can also function independently of B7 molecules. 1/4CTLA-4 is a highly conserved isoform encoded by exons 1 and 4 of the Ctla4 gene that lacks the ligand-binding and the transmembrane domains, and as yet, its function is not known. To investigate the function of 1/4CTLA-4, we generated transgenic (Tg) mice overexpressing this variant. Cytokine production by 1/4CTLA-4 Tg T cells was elevated compared with wild type T cells. The frequency of CD44high memory T cells in 1/4CTLA-4 Tg mice was increased, and as the mice aged, the frequency further increased. 1/4CTLA-4 Tg mice >1 y old had increased expression of T cell activation markers and developed spontaneous autoimmunity, including elevated production of autoantibodies. In contrast with young 1/4CTLA-4 Tg mice, aged 1/4CTLA-4 Tg mice had elevated frequencies of Foxp3+ regulatory T cells, but the regulatory T cells from these mice were not able to inhibit colitis development. Collectively, these data suggest that the function of the 1/4CTLA-4 isoform is distinct from that of CTLA-4 in that it enhances T cell activation and promotes autoimmunity rather than inhibiting immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
21. The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo.
- Author
-
Yang, Jun, Riella, Leonardo V., Chock, Susanne, Tao Liu, Xiaozhi Zhao, Xueli Yuan, Paterson, Alison M., Watanabe, Toshihiko, Vanguri, Vijay, Yagita, Hideo, Azuma, Miyuki, Blazar, Bruce R., Freeman, Gordon J., Rodig, Scott J., Sharpe, Arlene H., Chandraker, Anil, and Sayegh, Mohamed H.
- Subjects
- *
LIGANDS (Biochemistry) , *T cells , *IMMUNE response , *HEART transplantation , *CELL culture , *IMMUNOLOGY - Abstract
The programmed death ligand 1 (PDL1)/programmed death 1 (PD1) costimulatory pathway plays an important role in the inhibition of alloimmune responses as well as in the induction and maintenance of peripheral tolerance. It has been demonstrated recently that PDL1 also can bind B7.1 to inhibit T cell responses in vitro. Using the bm12 into B6 heart transplant model, we investigated the functional significance of this interaction in alloimmune responses in vivo. PD1 blockade unlike PDL1 blockade failed to accelerate bm12 allograft rejection, suggesting a role for an additional binding partner for PDL1 other than PD1 in transplant rejection. PDL1 blockade was able to accelerate allograft rejection in B7.2-deficient recipients but not B7.1-deficient recipients, indicating that PDL1 interaction with B7.1 was important in inhibiting rejection. Administration of the novel 2H11 anti-PDL1 mAb, which only blocks the PDL1-B7.1 interaction, aggravated chronic injury of bm12 allografts in B6 recipients. Aggravated chronic injury was associated with an increased frequency of alloreactive IFN-γ-, IL-4-, and IL-6-producing splenocytes and a decreased percentage of regulatory T cells in the recipients. Using an in vitro cell culture assay, blockade of the interaction of PDL1 on dendritic cells with B7.1 on T cells increased IFN-γ production from alloreactive CD4+ T cells, whereas blockade of dendritic cell B7.1 interaction with T cell PDL1 did not. These data indicate that PDL1 interaction with B7.1 plays an important role in the inhibition of alloimmune responses in vivo and suggests a dominant direction for PDL1 and B7.1 interaction. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
22. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice.
- Author
-
Mueller, Scott N., Vanguri, Vijay K., Sang-Jun Ha, West, Erin E., Keir, Mary E., Glickman, Jonathan N., Sharpe, Arlene H., Ahmed, Rafi, and Ha, Sang-Jun
- Subjects
- *
HEMATOPOIETIC stem cells , *T cells , *LABORATORY mice , *IMMUNOPATHOLOGY , *IMMUNE response , *LYMPHOCYTIC choriomeningitis virus , *MOLECULAR cloning , *ANIMAL experimentation , *BONE marrow , *CHRONIC diseases , *LIGANDS (Biochemistry) , *MICE , *RESEARCH funding , *VIRUS diseases , *LYMPHOCYTE count , *VIRAL meningitis - Abstract
The inhibitory receptor programmed death 1 (PD-1) is upregulated on antigen-specific CD8+ T cells during persistent viral infections. Interaction with PD-1 ligand 1 (PD-L1) contributes to functional exhaustion of responding T cells and may limit immunopathology during infection. PD-L1 is expressed on both hematopoietic and nonhematopoietic cells in tissues. However, the exact roles of PD-L1 on hematopoietic versus nonhematopoietic cells in modulating immune responses are unclear. Here we used bone marrow chimeric mice to examine the effects of PD-L1 deficiency in hematopoietic or nonhematopoietic cells during lymphocytic choriomeningitis virus clone 13 (LCMV CL-13) infection. We found that PD-L1 expression on hematopoietic cells inhibited CD8+ T cell numbers and function after LCMV CL-13 infection. In contrast, PD-L1 expression on nonhematopoietic cells limited viral clearance and immunopathology in infected tissues. Together, these data demonstrate that there are distinct roles for PD-L1 on hematopoietic and nonhematopoietic cells in regulating CD8+ T cell responses and viral clearance during chronic viral infection. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. Role of PD-1 in regulating acute infections
- Author
-
Brown, Keturah E, Freeman, Gordon J, Wherry, E John, and Sharpe, Arlene H
- Subjects
- *
INFECTION , *T cells , *NATURAL immunity , *MACROPHAGES , *B cells , *IMMUNE response , *IMMUNOLOGY - Abstract
While the role of PD-1 in inhibiting immunity during chronic infections is well established, its functions during acute infections are much less clear. The PD-1 pathway can dampen CD8 T cell responses during some acute infections and restrain responses by ‘helpless’ CD8 memory T cells. An emerging role for PD-1 in innate immunity has been revealed by recent studies showing that PD-1 can limit function of DC and macrophages as well as T cell independent B cell responses. Thus, PD-1 can influence adaptive immune responses during acute infections, though precisely how this regulation occurs is only just beginning to be appreciated. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.